Relationship between cholelithiasis and metabolic syndrome: the role of genetic factors
https://doi.org/10.31146/1682-8658-ecg-203-7-204-210
Abstract
The incidence of gallstone disease (GSD) and metabolic syndrome (MS) is increasing every year. The ICD-10 does not have the diagnosis of “metabolic syndrome” and it has been coded on the basis of the diseases despite its wide prevalence now. These are multifactorial diseases, the pathogenesis of which is intertwined and mutually aggravate their courses. There are both external and internal reasons of forming the stones in the biliary tract. Genetic factors play a significant role in the internal causes of cholelithiasis. The genetic characteristics of the patient allow to work out a personalized approach. It increases the success of drug therapy. MS is one of the main predisposing factors for the development of cholelithiasis. It also leads to more severe course of the latter. The pathogenetic mechanisms of the patologies developments are considered in the article presented with the special attention paid to the genetic component of cholelithiasis.
About the Authors
Maria S. Novikova
Novosibirsk State University
Russian Federation
Russian Federation
Evgenia V. Shrayner
Novosibirsk State University; Institute of chemical, Institute of Chemical Biology and Fundamental Medicine of the SB RAS
Russian Federation
Russian Federation
Galina I. Lifshits
Novosibirsk State University; Institute of chemical, Institute of Chemical Biology and Fundamental Medicine of the SB RAS
Russian Federation
Russian Federation
Nataly V. Kokh
Novosibirsk State University; Institute of chemical, Institute of Chemical Biology and Fundamental Medicine of the SB RAS
Russian Federation
Russian Federation
Anatoly I. Khavkin
Research Clinical Institute of Childhood of the Moscow Region»; Russian National Research Medical University named after Pirogov; Belgorod State Research University
Russian Federation
Russian Federation
References
1. Frybova B., Drabek J., Lochmannova J., Douda L., Hlava S., Zemkova D. et al. Cholelithiasis and choledocholithiasis in children: risk factors for development. PLoS One 2018. 13(5): e0196475. doi:10.1371/journal.pone.0196475
2. Nikitin I. G., Volnukhin A. V. Cholelithiasis: epidemiological data, key aspects of the pathogenesis and comorbidity, relevant therapeutic targets.Russian Medical Inquiry. 2020. 4(5): 290-296. (In Russ.) doi: 10.32364/2587-6821-2020-4-5-290-296. @@Никитин И. Г., Волнухин А. В. Желчнокаменная болезнь: эпидемиологические данные, ключевые аспекты патогенеза и коморбидности, актуальные терапевтические мишени. РМЖ. Медицинское обозрение. 2020. 4(5): 290-296. doi: 10.32364/2587-6821-2020-4-5-290-296
3. Cabrera C., Pabón J., Caicedo C., Cabrera B., Villamil C., Chávez B., et al. Cholelithiasis and associated complications in pediatric patients. Cir Pediatr 2020. 33(4): 172-176
4. Agrawal V., Tiwari A., Sharma D., Agrawal R. Etiology-Based Decision-Making Protocol for Pediatric Cholelithiasis. Indian Pediatr 2021. 58(8): 729-732
5. Cuzzolin L., Oggiano A., Clemente M., Locci C., Antonucci L., Antonucci R. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough? Fundam Clin Pharmacol 2021. 35(1): 40-52. doi:10.1111/fcp.12577
6. Diez S., Müller H., Weiss C., Schellerer V., Besendörfer M. Cholelithiasis and cholecystitis in children and adolescents: Does this increasing diagnosis require a common guideline for pediatricians and pediatric surgeons? BMC Gastroenterol 2021. 21(1): 186. doi:10.1186/s12876-021-01772-y
7. Koh N. V., Voronina E. N., Efremova T. V., Soldatova G. S., Lifshic G. I. Genetic risk factors of cytolysis syndrome in the treatment of recrudescence of chronic cardiovascular diseases.Russian Journal of Cardiology. 2018. 23(10): 76-82. (In Russ.) doi: 10.15829/1560-4071-2018-10-76-82. @@Кох Н. В., Воронина Е. Н., Ефремова Т. В., Солдатова Г. С., Лифшиц Г. И. Генетические факторы риска синдрома цитолиза при терапии обострений хронических сердечнососудистых заболеваний. Российский кардиологический журнал. 2018. Т. 23. № 10. С. 76-82. doi: 10.15829/1560-4071-2018-10-76-82
8. Steventon G. Uridine diphosphate glucuronosyltransferase 1A1. Xenobiotica 2020. 50(1): 64-76. doi:10.1080/00498254.2019.1617910
9. Waddell J., Rickman N., He M., Tang N., Bearer C. Choline supplementation prevents the effects of bilirubin on cerebellar-mediated behavior in choline-restricted Gunn rat pups. Pediatr Res 2021. 89(6): 1414-1419. doi:10.1038/s41390-020-01187-7
10. Kim J., Cheong H., Park B., et al.Comprehensive variant screening of the UGT gene family. Yonsei Med J 2014. 55(1): 232-239. doi: 10.3349/ymj.2014.55.1.232
11. Sidorenko D. V., Nazarov V. D., Volnikova E. G., Kondrasheva E. A., Peshkova N. G., Kovaleva I. S. et al. Dependence of blood biochemical parameters on various genotypes of the UGT1A1 gene associated with Gilbert’s syndrome. Klinicheskaja laboratornaja diagnostika (Russian Clinical Laboratory Diagnostics). 2022. 67(2): 69-75. doi: 10.51620/0869-2084-2022-67-2-69-75. @@Сидоренко Д. В., Назаров В. Д., Волникова Е. Г., Кондрашева Е. А., Пешкова Н. Г., Ковалева И. С. и др. Зависимость биохимических показателей крови от различных генотипов гена UGT1A1, ассоциированного с синдромом Жильбера. Клиническая лабораторная диагностика. 2022. Т. 67. № 2. С. 69-75. doi:10.51620/0869-2084-2022-67-2-69-75
12. Fiorucci S., Distrutti E. The Pharmacology of Bile Acids and Their Receptors. Handb Exp Pharmacol 2019. 256: 3-18. doi:10.1007/164_2019_238
13. Siddiqui A. I., Tahani A. Biliary Atresia. StatPearls [Internet] 2022. Treasure Island (FL): StatPearls Publishing. PMID: 30725947
14. Chen G., Liu J., Huang Y., Wu Y., Lu X., Dong R., et al. Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia: a randomized controlled trial. Pediatr Surg Int 2021. 37(8): 1089-1097. doi:10.1007/s00383-021-04916-z
15. Petrov V., Fernández-Peralbo M., Derks R., Knyazeva E., Merzlikin N., Sazonov A., et al. Biliary Microbiota and Bile Acid Composition in Cholelithiasis. Biomed Res Int 2020. 2020:1242364. doi:10.1155/2020/1242364
16. Laithavewat L., Grundy-Warr C., Khuntikeo N., Andrews R., Petney T., Yongvanit P., et al. Analysis of a school-based health education model to prevent opisthorchiasis and cholangiocarcinoma in primary school children in northeast Thailand. Glob Health Promot 2020. 27(1): 15-23. doi:10.1177/1757975918767622
17. Chen H., Wu S., Hsu S., Liou B., Chen H., Chang M. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. J Biomed Sci 2018. 25(1): 75. doi:10.1186/s12929-018-0475-8
18. Kesrouani A., Nassif N., Nasr B., Choueiry E., Chalouhi G. Ultrasound characteristics and outcome of prenatally diagnosed fetal cholelithiasis. J Matern Fetal Neonatal Med 2019. 32(12): 2095-2099. doi:10.1080/14767058.2018.1424819
19. Tropeano A., Corica D., Li Pomi A. et al. The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review. Eur J Endocrinol 2021. 185(2): 265-278. doi:10.1530/EJE-21-0238
20. Bovolini A., Garcia J., Andrade M., Duarte J. Metabolic Syndrome Pathophysiology and Predisposing Factors.Int J Sports Med 2021. 42(3):199-214. doi:10.1055/a-1263-0898
21. Gallardo-Alfaro L., et al. Leisure-Time Physical Activity, Sedentary Behaviour and Diet Quality are Associated with Metabolic Syndrome Severity: The PREDIMED-Plus Study. Nutrients 2020. 12(4): 1013. doi:10.3390/nu12041013
22. Bull F., Al-Ansari S., Biddle S., et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 2020. 54(24): 1451-1462. doi:10.1136/bjsports-2020-102955
23. Lifshits G. I., Shrayner E. V., Kokh N. V., Voronina E. N., Khavkin A. I. Clinical signifi cance of studying the genetic polymorphism of adhesion factors in Helicobacter pylori - associated diseases. Experimental and Clinical Gastroenterology. 2022. 197(1): 18-23. (In Russ.) doi: 10.31146/1682-8658-ecg-197-1-18-23. @@Лифшиц Г. И., Шрайнер Е. В., Кох Н. В., Воронина Е. Н., Хавкин А. И. Клиническое значение изучения генетического полиморфизма факторов адгезии при Helicobacter pylori-ассоциированных заболеваниях. Экспериментальная и клиническая гастроэнтерология. 2022. Т. 1. № 197. С. 18-23. doi: 10.31146/1682-8658-ecg-197-1-18-23
Review
For citations:
Novikova M.S., Shrayner E.V., Lifshits G.I., Kokh N.V., Khavkin A.I. Relationship between cholelithiasis and metabolic syndrome: the role of genetic factors. Experimental and Clinical Gastroenterology. 2022;(7):204-210. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-203-7-204-210
Views:
294
Email this article 